85 related articles for article (PubMed ID: 20560287)
21. [Study on treatment effect and mechanism of Hirsutella sinensis mycelium in idiopathic pulmonary fibrosis in rats].
Shou QY; Fu HY; Zhang LZ; Cai YQ; Chen FM; Chen ML
Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3618-23. PubMed ID: 23477151
[TBL] [Abstract][Full Text] [Related]
22. First-in-class antifibrotic therapy targeting type 1 lysophosphatidic acid receptor.
Im DS
Arch Pharm Res; 2012 Jun; 35(6):945-8. PubMed ID: 22870802
[TBL] [Abstract][Full Text] [Related]
23. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
[TBL] [Abstract][Full Text] [Related]
24. [How to face the current status of therapies for idiopathic pulmonary fibrosis].
Zhang DP
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):844-7. PubMed ID: 24507398
[No Abstract] [Full Text] [Related]
25. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
26. Advances in understanding of idiopathic pulmonary fibrosis.
Wang ZL
Chin Med J (Engl); 2009 Apr; 122(7):844-57. PubMed ID: 19493401
[No Abstract] [Full Text] [Related]
27. [Idiopathic pulmonary fibrosis].
Selman M; Mejía M; Pardo A
Rev Invest Clin; 2009; 61(3):233-42. PubMed ID: 19736812
[No Abstract] [Full Text] [Related]
28. Lost in translation; from animal models of pulmonary fibrosis to human disease.
Maher TM; Wells AU
Respirology; 2009 Sep; 14(7):915-6. PubMed ID: 19740253
[No Abstract] [Full Text] [Related]
29. [Idiopathic pulmonary fibrosis: in search of an effective treatment].
Selman M; Navarro C; Gaxiola M
Arch Bronconeumol; 2005 Dec; 41 Suppl 5():15-20. PubMed ID: 17125702
[No Abstract] [Full Text] [Related]
30. Statin Therapy and Lung Disorders.
Mari PV; Lombardi F; Flore MC; Richeldi L
Am J Respir Crit Care Med; 2019 Oct; 200(7):921-923. PubMed ID: 31247147
[No Abstract] [Full Text] [Related]
31. Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.
Leppäranta O; Tikkanen JM; Bespalov MM; Koli K; Myllärniemi M
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):448-55. PubMed ID: 23258233
[TBL] [Abstract][Full Text] [Related]
32. Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis.
Ricci A; Cherubini E; Ulivieri A; Lavra L; Sciacchitano S; Scozzi D; Mancini R; Ciliberto G; Bartolazzi A; Bruno P; Graziano P; Mariotta S
J Cell Physiol; 2013 Jan; 228(1):235-41. PubMed ID: 22689412
[TBL] [Abstract][Full Text] [Related]
33. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.
Azuma A
Expert Rev Respir Med; 2010 Jun; 4(3):301-10. PubMed ID: 20524912
[TBL] [Abstract][Full Text] [Related]
34. STAT3: a central mediator of pulmonary fibrosis?
Prêle CM; Yao E; O'Donoghue RJ; Mutsaers SE; Knight DA
Proc Am Thorac Soc; 2012 Jul; 9(3):177-82. PubMed ID: 22802294
[TBL] [Abstract][Full Text] [Related]
35. A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells.
Luo Y; Xu W; Chen H; Warburton D; Dong R; Qian B; Selman M; Gauldie J; Kolb M; Shi W
J Pathol; 2015 Jul; 236(3):384-94. PubMed ID: 25779936
[TBL] [Abstract][Full Text] [Related]
36. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.
Raghu G; Selman M
Am J Respir Crit Care Med; 2015 Feb; 191(3):252-4. PubMed ID: 25635489
[No Abstract] [Full Text] [Related]
37. Could N-acetylcysteine slow progression of idiopathic pulmonary fibrosis by inhibiting EMT?
Wolters PJ
Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L803-4. PubMed ID: 19700642
[No Abstract] [Full Text] [Related]
38. Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis.
Stewart ID; Nanji H; Figueredo G; Fahy WA; Maher TM; Ask AJ; Maharaj S; Ask K; Kolb M; Jenkins GR
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33766945
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Idiopathic Pulmonary Fibrosis.
Carlos WG; Strek ME; Wang TS; Patel H; Raghu G; Wilson KC; Thomson CC
Ann Am Thorac Soc; 2016 Jan; 13(1):115-7. PubMed ID: 26730865
[No Abstract] [Full Text] [Related]
40. Idiopathic Pulmonary Fibrosis: A Systemic Disease?
Man L; Hong P
Chin Med J (Engl); 2017 Sep; 130(17):2140-2141. PubMed ID: 28836568
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
